Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2003
11/06/2003WO2002060491A3 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
11/06/2003US20030208096 Method for delivering radiation to an intraluminal site in the body
11/06/2003US20030208078 Heterocyclic amines administered to mammals for detection of nervous system disorders
11/06/2003US20030207797 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030206903 Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/06/2003US20030206865 Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy
11/06/2003US20030206860 Radiopaque implantable collagenous biomaterial device
11/06/2003US20030206858 Metal complex-containing pharmaceutical agents
11/06/2003US20030206857 Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
11/06/2003US20030206856 Measures cerebral metabolism before and after administering the external stimuli or treatment, and employs a behavioral clamp to control behavioral influences on the subject's brain after administration
11/05/2003EP1358890A1 Benzothienyl analogue of somatostatine, selective for certain somatostatin receptors
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1357947A1 Gastric emptying
11/05/2003EP0968001B1 Method for the detection and localization of malignant human pancreatic tumours
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/04/2003US6641999 Probing method for identifying antibodies specific for selected antigens
11/04/2003CA2123570C Cocaine receptor binding ligands
11/04/2003CA2040555C Cloned glutamic acid decarboxylase
10/2003
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089013A1 Cyclooxygenase-2 selective agents useful as imaging probes and related methods
10/30/2003WO2003088898A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003057837A8 Methods for using anti-muc18 antibodies
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
10/30/2003WO2003031452A3 4-haloethenylphenyl tropane:serotonin transporter imaging agents
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2002087498A3 Diagnostic imaging compositions, their methods of synthesis and use
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203415 Comprises polypeptide for, diagnosis, detection and treatment of cancer
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003US20030202936 PH sensitivity; releasing drugs
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/29/2003EP1356827A1 Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP0946526B1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/28/2003US6638508 Drug delivery; therapy for liver disorders
10/28/2003US6638207 Radioactive seed with multiple markers and method for using same
10/28/2003US6638205 Radioactive medical device for radiation therapy
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/23/2003WO2003086476A1 Technetium-labeled rotenone derivatives, and methods of use thereof
10/23/2003WO2003086475A1 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
10/23/2003WO2003086172A2 Method for tagging colonic residue
10/23/2003WO2003055379A3 Method using a surface-selective nonlinear optical technique for imaging of biological samples
10/23/2003WO2003040287A3 Isotope-coded affinity tag
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2002068000A3 Polymeric imagable brachytherapy seed
10/23/2003US20030198598 Polypeptide derivatives
10/23/2003US20030198595 Completitive binding
10/23/2003US20030198594 Imaging of drug accumulation as a guide to antitumor therapy
10/23/2003US20030198593 Complex of radioactive material with salicylic acid compound; radiation resistance
10/23/2003CA2481692A1 Method for tagging colonic residue
10/22/2003EP1353937A2 Specific human antibodies for selective cancer therapy
10/22/2003CN1450915A Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
10/22/2003CN1450911A New clinical parameters for determining hematologic toxicity proior to radioimmunotherapy
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/21/2003US6635618 Glycopeptide phosphonate derivatives
10/21/2003US6635235 Bifunctional chelating agent for the design and development of site specific radiopharmaceuticals and biomolecule conjugation strategy
10/21/2003US6635234 Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
10/21/2003CA2093896C Hormone labelling with rhenium and technetium
10/16/2003WO2003085093A2 Antibodies that specifically bind to gmad
10/16/2003WO2003084575A1 Pendant fatty acid imaging agents
10/16/2003WO2003084574A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003WO2003084508A1 Delivery of a substance to a pre-determined site
10/16/2003WO2003028643A3 Targeted therapeutic lipid constructs having cell surface targets
10/16/2003WO2003011342A3 Targeted polymeric delivery systems
10/16/2003WO2002087630A3 Determination of gastric and oesophageal tumours
10/16/2003WO2002056670A3 Activatable imaging probes
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194390 Alkyl cyanoacrylate and inhibitor and aggregate structure formed; alkyl fatty ester, opacifier; ablating tissue by blocking blood flow
10/16/2003US20030194373 Chelate compound capable of complexing a radionuclide metal or halogen; cancer diagnosis; tumor staging and prognosis
10/16/2003US20030194372 Radioimaging probes and the use thereof
10/16/2003CA2480052A1 Antibodies that specifically bind to gmad
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351713A1 Anti-tenascin monoclonal antibody therapy for lymphoma
10/15/2003EP1351712A2 Targeted combination immunotherapy of cancer and infectious diseases
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/15/2003CN1448183A Tumour-curing specific target guiding administration system and use in preparation of tumour-curing medicine
10/14/2003US6632176 Products and methods for brachytherapy
10/14/2003CA2317019C Magnetically responsive composition
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082347A1 Diagnostic for diseases associated with cerebrospinal fluid circulation failure
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2002060955A3 Modified antibodies and methods of use
10/09/2003US20030191354 System having a carrier substrate and a ti/p or. a1/p coating
10/09/2003US20030190283 Preparations for evaluating eliminative ability of stomach
10/09/2003CA2479750A1 Fibrinogen binding moieties
10/08/2003EP1350109A1 Marker for inflammatory conditions
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP0533845B1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 243